Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis

Immunity

Volumn 18, Issue 6, 2003, Pages 751-762

  Jun, Jesse E ^a   Wilson, Lauren E ^a   Vinuesa, Carola G ^a   Lesage, Sylvie ^a   Blery, Mathieu ^a   Miosge, Lisa A ^a   Cook, Matthew C ^b   Kucharska, Edyta M ^a   Hara, Hiromitsu ^c,d   Penninger, Josef M ^c,d   Domashenz, Heather ^a   Hong, Nancy A ^e   Glynne, Richard J ^e   Nelms, Keats A ^a,b   Goodnow, Christopher C ^a  

^a Biology and Environment   (Australia)

^b Phenomix Australia   (Australia)

^c INSTITUTE OF MOLECULAR BIOTECHNOLOGY   (Austria)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e Phenomix Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CALCIUM ION; CASPASE RECRUITMENT DOMAIN 11 PROTEIN; CD28 ANTIGEN; ETHYLNITROSOUREA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE ASSOCIATED GUANYLATE KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOTRANSFERASE; REGULATOR PROTEIN; STRESS ACTIVATED PROTEIN KINASE; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPY; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC CONSERVATION; HUMORAL IMMUNITY; HYPERIMMUNOGLOBULINEMIA E; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MOUSE; MOUSE STRAIN; MUTAGENESIS; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0037827638     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(03)00141-9     Document Type: Article

References (71)

1. Alkalay I., Yaron A., Hatzubai A., Jung S., Avraham A., Gerlitz O., Pashut-Lavon I., Ben-Neriah Y. In vivo stimulation of I kappa B phosphorylation is not sufficient to activate NF-kappa B. Mol. Cell. Biol. 15:1995;1294-1301.
2. Aronica M.A., Mora A.L., Mitchell D.B., Finn P.W., Johnson J.E., Sheller J.R., Boothby M.R. Preferential role for NF-kappa B/Rel signaling in the type 1 but not type 2 T cell-dependent immune response in vivo. J. Immunol. 163:1999;5116-5124.
3. Bajpai U.D., Zhang K., Teutsch M., Sen R., Wortis H.H. Bruton's tyrosine kinase links the B cell receptor to nuclear factor kappaB activation. J. Exp. Med. 191:2000;1735-1744.
4. Bertin J., Guo Y., Wang L., Srinivasula S.M., Jacobson M.D., Poyet J.L., Merriam S., Du M.Q., Dyer M.J., Robison K.E.et al. CARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10/CLAP and activates NF-kappa B. J. Biol. Chem. 275:2000;41082-41086.
5. Bertin J., Wang L., Guo Y., Jacobson M.D., Poyet J.L., Srinivasula S.M., Merriam S., DiStefano P.S., Alnemri E.S. CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B. J. Biol. Chem. 276:2001;11877-11882.
6. Bouillet P., Purton J.F., Godfrey D.I., Zhang L.C., Coultas L., Puthalakath H., Pellegrini M., Cory S., Adams J.M., Strasser A. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature. 415:2002;922-926.
7. Burkhard P., Stetefeld J., Strelkov S.V. Coiled coils. a highly versatile protein folding motif Trends Cell Biol. 11:2001;82-88.
8. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature. 410:2001;37-40.
9. Chin A.I., Dempsey P.W., Bruhn K., Miller J.F., Xu Y., Cheng G. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature. 416:2002;190-194.
10. DeFranco A.L. The complexity of signaling pathways activated by the BCR. Curr. Opin. Immunol. 9:1997;296-308.
11. Dintzis H.M., Dintzis R.Z., Vogelstein B. Molecular determinants of immunogenicity. the immunon model of immune response Proc. Natl. Acad. Sci. USA. 73:1976;3671-3675.
12. Dolmetsch R.E., Lewis R.S., Goodnow C.C., Healy J.I. Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature. 386:1997;855-858.
13. Dong C., Yang D.D., Tournier C., Whitmarsh A.J., Xu J., Davis R.J., Flavell R.A. JNK is required for effector T-cell function but not for T-cell activation. Nature. 405:2000;91-94.
14. Dorado B., Portoles P., Ballester S. NF-kappaB in Th2 cells. delayed and long-lasting induction through the TCR complex Eur. J. Immunol. 28:1998;2234-2244.
15. Fanning A.S., Anderson J.M. Protein modules as organizers of membrane structure. Curr. Opin. Cell Biol. 11:1999;432-439.
16. Fruman D.A., Satterthwaite A.B., Witte O.N. Xid-like phenotypes. a B cell signalosome takes shape Immunity. 13:2000;1-3.
17. Gaide O., Martinon F., Micheau O., Bonnet D., Thome M., Tschopp J. Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-kappaB activation. FEBS Lett. 496:2001;121-127.
18. Gaide O., Favier B., Legler D.F., Bonnet D., Brissoni B., Valitutti S., Bron C., Tschopp J., Thome M. CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activation. Nat. Immunol. 3:2002;836-843.
19. Gerondakis S., Grossmann M., Nakamura Y., Pohl T., Grumont R. Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function. transgenics and knockouts Oncogene. 18:1999;6888-6895.
20. Glynne R., Akkaraju S., Healy J.I., Rayner J., Goodnow C.C., Mack D.H. How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis. Nature. 403:2000;672-676.
21. Goodnow C.C. Pathways for self-tolerance and the treatment of autoimmune diseases. Lancet. 357:2001;2115-2121.
22. Grumont R.J., Rourke I.J., O'Reilly L.A., Strasser A., Miyake K., Sha W., Gerondakis S. B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J. Exp. Med. 187:1998;663-674.
23. Guerder S., Rincon M., Schmitt-Verhulst A.M. Regulation of activator protein-1 and NF-kappa B in CD8+ T cells exposed to peripheral self-antigens. J. Immunol. 166:2001;4399-4407.
24. Hara H., Wada T., Bakal C., Kozieradzki I., Suzuki S., Suzuki N., Nghiem M., Griffiths E.K., Krawczyk C., Bauer B.et al. The MAGUK family protein CARD11 is essential for lymphocyte activation. Immunity. 18:2003;763-775. this issue,
25. Hashimoto A., Okada H., Jiang A., Kurosaki M., Greenberg S., Clark E.A., Kurosaki T. Involvement of guanosine triphosphatases and phospholipase C-gamma2 in extracellular signal-regulated kinase, c-Jun NH2-terminal kinase, and p38 mitogen-activated protein kinase activation by the B cell antigen receptor. J. Exp. Med. 188:1998;1287-1295.
26. Healy J.I., Dolmetsch R.E., Timmerman L.A., Cyster J.G., Thomas M.L., Crabtree G.R., Lewis R.S., Goodnow C.C. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity. 6:1997;419-428.
27. Hilliard B.A., Mason N., Xu L., Sun J., Lamhamedi-Cherradi S.E., Liou H.C., Hunter C., Chen Y.H. Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation. J. Clin. Invest. 110:2002;843-850.
28. Hitotsumachi S., Carpenter D.A., Russell W.L. Dose-repetition increases the mutagenic effectiveness of N-ethyl-N-nitrosourea in mouse spermatogonia. Proc. Natl. Acad. Sci. USA. 82:1985;6619-6621.
29. Jenkins M.K., Pardoll D.M., Mizuguchi J., Chused T.M., Schwartz R.H. Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper T-lymphocyte clones. Proc. Natl. Acad. Sci. USA. 84:1987;5409-5413.
30. Kane L.P., Lin J., Weiss A. It's all Rel-ative. NF-kappaB and CD28 costimulation of T-cell activation Trends Immunol. 23:2002;413-420.
31. Kobayashi K., Inohara N., Hernandez L.D., Galan J.E., Nunez G., Janeway C.A., Medzhitov R., Flavell R.A. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature. 416:2002;194-199.
32. Kurosaki T. Regulation of B-cell signal transduction by adaptor proteins. Nat. Rev. Immunol. 2:2002;354-363.
33. LaSalle J.M., Tolentino P.J., Freeman G.J., Nadler L.M., Hafler D.A. Early signaling defects in human T cells anergized by T cell presentation of autoantigen. J. Exp. Med. 176:1992;177-186.
34. Lederer J.A., Liou J.S., Kim S., Rice N., Lichtman A.H. Regulation of NF-kappa B activation in T helper 1 and T helper 2 cells. J. Immunol. 156:1996;56-63.
35. Leitenberg D., Bottomly K. Regulation of naive T cell differentiation by varying the potency of TCR signal transduction. Semin. Immunol. 11:1999;283-292.
36. Li Q., Verma I.M. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2:2002;725-734.
37. Li W., Whaley C.D., Mondino A., Mueller D.L. Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4+ T cells. Science. 271:1996;1272-1276.
38. Liou H.C., Jin Z., Tumang J., Andjelic S., Smith K.A., Liou M.L. c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function. Int. Immunol. 11:1999;361-371.
39. Lucas P.J., Negishi I., Nakayama K., Fields L.E., Loh D.Y. Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J. Immunol. 154:1995;5757-5768.
40. Lupas A., Van Dyke M., Stock J. Predicting coiled coils from protein sequences. Science. 252:1991;1162-1164.
41. Lyons A.B., Parish C.R. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods. 171:1994;131-137.
42. Macian F., Garcia-Cozar F., Im S.H., Horton H.F., Byrne M.C., Rao A. Transcriptional mechanisms underlying lymphocyte tolerance. Cell. 109:2002;719-731.
43. McAllister-Lucas L.M., Inohara N., Lucas P.C., Ruland J., Benito A., Li Q., Chen S., Chen F.F., Yamaoka S., Verma I.M.et al. Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction. J. Biol. Chem. 276:2001;30589-30597.
44. Miosge L.A., Blasioli J., Blery M., Goodnow C.C. Analysis of an ethylnitrosourea-generated mouse mutation defines a cell intrinsic role of nuclear factor kappaB2 in regulating circulating B cell numbers. J. Exp. Med. 196:2002;1113-1119.
45. Montell C. Visual transduction in Drosophila. Annu. Rev. Cell Dev. Biol. 15:1999;231-268.
46. Petro J.B., Khan W.N. Phospholipase C-gamma 2 couples Bruton's tyrosine kinase to the NF-kappaB signaling pathway in B lymphocytes. J. Biol. Chem. 276:2001;1715-1719.
47. Petro J.B., Rahman S.M., Ballard D.W., Khan W.N. Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement. J. Exp. Med. 191:2000;1745-1754.
48. Pomerantz J.L., Denny E.M., Baltimore D. CARD11 mediates factor-specific activation of NF-kappaB by the T cell receptor complex. EMBO J. 21:2002;5184-5194.
49. Reth M. Oligomeric antigen receptors. a new view on signaling for the selection of lymphocytes Trends Immunol. 22:2001;356-360.
50. Richards J.D., Dave S.H., Chou C.H., Mamchak A.A., DeFranco A.L. Inhibition of the MEK/ERK signaling pathway blocks a subset of B cell responses to antigen. J. Immunol. 166:2001;3855-3864.
51. Ruland J., Duncan G.S., Elia A., del Barco Barrantes I., Nguyen L., Plyte S., Millar D.G., Bouchard D., Wakeham A., Ohashi P.S., Mak T.W. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-κB and neural tube closure. Cell. 104:2001;33-42.
52. Rust S., Funke H., Assmann G. Mutagenically separated PCR (MS-PCR). a highly specific one step procedure for easy mutation detection Nucleic Acids Res. 21:1993;3623-3629.
53. Saijo K., Mecklenbrauker I., Santana A., Leitger M., Schmedt C., Tarakhovsky A. Protein kinase C beta controls nuclear factor kappaB activation in B cells through selective regulation of the IkappaB kinase alpha. J. Exp. Med. 195:2002;1647-1652.
54. Schwartz R.H. T cell anergy. Annu. Rev. Immunol. 21:2002;305-334.
55. Scott K., Zuker C.S. Assembly of the Drosophila phototransduction cascade into a signalling complex shapes elementary responses. Nature. 395:1998;805-808.
56. Seetharaman R., Mora A.L., Nabozny G., Boothby M., Chen J. Essential role of T cell NF-kappa B activation in collagen-induced arthritis. J. Immunol. 163:1999;1577-1583.
57. Sheng M., Sala C. PDZ domains and the organization of supramolecular complexes. Annu. Rev. Neurosci. 24:2001;1-29.
58. Sloan-Lancaster J., Allen P.M. Altered peptide ligand-induced partial T cell activation. molecular mechanisms and role in T cell biology Annu. Rev. Immunol. 14:1996;1-27.
59. Sperling A.I., Auger J.A., Ehst B.D., Rulifson I.C., Thompson C.B., Bluestone J.A. CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation. J. Immunol. 157:1996;3909-3917.
60. Su B., Jacinto E., Hibi M., Kallunki T., Karin M., Ben-Neriah Y. JNK is involved in signal integration during costimulation of T lymphocytes. Cell. 77:1994;727-736.
61. Su T.T., Guo B., Kawakami Y., Sommer K., Chae K., Humphries L.A., Kato R.M., Kang S., Patrone L., Wall R.et al. PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling. Nat. Immunol. 3:2002;780-786.
62. Sundstedt A., Sigvardsson M., Leanderson T., Hedlund G., Kalland T., Dohlsten M. In vivo anergized CD4+ T cells express perturbed AP-1 and NF-kappa B transcription factors. Proc. Natl. Acad. Sci. USA. 93:1996;979-984.
63. Tan J.E., Wong S.C., Gan S.K., Xu S., Lam K.P. The adaptor protein BLNK is required for B cell antigen receptor-induced activation of nuclear factor-kappa B and cell cycle entry and survival of B lymphocytes. J. Biol. Chem. 276:2001;20055-20063.
64. Toellner K.M., Luther S.A., Sze D.M., Choy R.K., Taylor D.R., MacLennan I.C., Acha-Orbea H. T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching. J. Exp. Med. 187:1998;1193-1204.
65. Turner M., Billadeau D.D. VAV proteins as signal integrators for multi-subunit immune-recognition receptors. Nat. Rev. Immunol. 2:2002;476-486.
66. Venkataraman L., Burakoff S.J., Sen R. FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells. J. Exp. Med. 181:1995;1091-1099.
67. Wang D., You Y., Case S.M., McAllister-Lucas L.M., Wang L., DiStefano P.S., Nunez G., Bertin J., Lin X. A requirement for CARMA1 in TCR-induced NF-kappa B activation. Nat. Immunol. 3:2002;830-835.
68. Wells A.D., Gudmundsdottir H., Turka L.A. Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J. Clin. Invest. 100:1997;3173-3183.
69. Wong S.C., Chew W.K., Tan J.E., Melendez A.J., Francis F., Lam K.P. Peritoneal CD5+ B-1 cells have signaling properties similar to tolerant B cells. J. Biol. Chem. 277:2002;30707-30715.
70. Yablonski D., Weiss A. Mechanisms of signaling by the hematopoietic-specific adaptor proteins, SLP-76 and LAT and their B cell counterpart, BLNK/SLP-65. Adv. Immunol. 79:2001;93-128.
71. + T cells to Th1 cells requires MAP kinase JNK2. Immunity. 9:1998;575-585.